Updated: AstraZeneca says there’s ‘very limited’ impact on Farxiga after US drug pricing negotiations

AstraZeneca has concluded its price negotiations with the IRA for its blockbuster drug Farxiga, in the latest update for pharma companies undergoing the process. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SphingoTec Announces Management Changes – Biotech Investments

EQS-Media / 26.03.2024 / 13:00 CET/CEST Hennigsdorf/Berlin, Germany, March 26, 2024 – Diagnostic company SphingoTec announces a significant change in its management team. Joerg Menten,

March 27, 2024

Brain bleeds in older adults linked to amyloid deposits in blood vessels

A common type of brain bleed in older adults, known as subdural hemorrhage, is associated with the presence of amyloid deposits in cerebral blood vessels,

December 27, 2023

Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss | Psychedelic Invest

Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.